American Regent recalls three lots of epinephrine injection over particulate matter, sterility conce
The recall, which the New Albany, Ohio-based company said covers product down to the consumer level, was issued due to the presence of particulate matter and lack of assurance of sterility.
The recall, which the New Albany, Ohio-based company said covers product down to the consumer level, was issued due to the presence of particulate matter and lack of assurance of sterility.1
The company stated that it had received customer complaints for leaking and cracked vials1 related to the affected product.
The source document provided is truncated beyond this point, and additional details that may appear in the full recall notice, including specific lot numbers, expiration dates, total quantities affected, health risk information, or instructions for consumers and providers, are not available in the record reviewed as of November 17, 2026.
Fact check notes
- Sentence removed
American Regent, Inc. announced on September 3, 2026, a voluntary nationwide recall of three lots of Epinephrine Injection, USP 30 mg/30 mL (1 mg/mL) multi dose vials.
copied source wording
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Where the check questioned a sentence, its note is shown above. Not investment advice.